0001894562-24-000012.txt : 20240223
0001894562-24-000012.hdr.sgml : 20240223
20240223170242
ACCESSION NUMBER: 0001894562-24-000012
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240221
FILED AS OF DATE: 20240223
DATE AS OF CHANGE: 20240223
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LEE ANN L.
CENTRAL INDEX KEY: 0001723629
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41536
FILM NUMBER: 24672381
MAIL ADDRESS:
STREET 1: 400 DEXTER AVENUE NORTH
STREET 2: SUITE 1200
CITY: SEATTLE
STATE: WA
ZIP: 98109
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Prime Medicine, Inc.
CENTRAL INDEX KEY: 0001894562
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 21 ERIE ST.
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-465-0013
MAIL ADDRESS:
STREET 1: 21 ERIE ST.
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
wk-form4_1708725737.xml
FORM 4
X0508
4
2024-02-21
0
0001894562
Prime Medicine, Inc.
PRME
0001723629
LEE ANN L.
C/O PRIME MEDICINE, INC.
21 ERIE STREET
CAMBRIDGE
MA
02139
0
1
0
0
Chief Technical Officer
0
Stock Option (right to buy)
8.49
2024-02-21
4
A
0
180995
0
A
2034-02-21
Common Stock
180995
180995
D
1/48th of the shares underlying this option vest and become exercisable in substantially equal monthly installments on each monthly anniversary of February 21, 2024, subject to the Reporting Person's continued service on each such vesting date.
/s/ Karen Brown, attorney-in-fact
2024-02-23